Brief: SinoMab Bioscience Posts HY Loss RMB134.1 Million
21/08/2023 12:49
Aug 21 (Reuters) - SinoMab BioScience Ltd 3681.HK :
* HY LOSS RMB134.1 MILLION VERSUS LOSS RMB143.8 MILLION
* HY REVENUE RMB1.4 MILLION
Further company coverage: 3681.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on Sinomab Bioscience
See all newsBrief: Sinomab Bioscience Posts HY Loss Of RMB127.4 Million
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience